

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | synaptic vesicle maturation (GO:0016188) | 5.72507981 |
| 2 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.31279934 |
| 3 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 5.23420847 |
| 4 | regulation of synaptic vesicle exocytosis (GO:2000300) | 5.01086222 |
| 5 | synaptic vesicle exocytosis (GO:0016079) | 4.94949830 |
| 6 | locomotory exploration behavior (GO:0035641) | 4.73057172 |
| 7 | glutamate secretion (GO:0014047) | 4.71501027 |
| 8 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 4.62773791 |
| 9 | regulation of synaptic vesicle transport (GO:1902803) | 4.38808915 |
| 10 | neurotransmitter secretion (GO:0007269) | 4.02209859 |
| 11 | vocalization behavior (GO:0071625) | 4.01444756 |
| 12 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 3.96412857 |
| 13 | regulation of synapse structural plasticity (GO:0051823) | 3.93181628 |
| 14 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 3.80295505 |
| 15 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.80047606 |
| 16 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.72989878 |
| 17 | layer formation in cerebral cortex (GO:0021819) | 3.58649865 |
| 18 | cell communication by electrical coupling (GO:0010644) | 3.56476860 |
| 19 | exploration behavior (GO:0035640) | 3.56434138 |
| 20 | cellular potassium ion homeostasis (GO:0030007) | 3.52095094 |
| 21 | proline transport (GO:0015824) | 3.49685472 |
| 22 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.48619503 |
| 23 | * activation of protein kinase A activity (GO:0034199) | 3.48566849 |
| 24 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.47900208 |
| 25 | Golgi transport vesicle coating (GO:0048200) | 3.47786307 |
| 26 | COPI coating of Golgi vesicle (GO:0048205) | 3.47786307 |
| 27 | neuronal action potential propagation (GO:0019227) | 3.46866340 |
| 28 | sodium ion export (GO:0071436) | 3.45431151 |
| 29 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.44751248 |
| 30 | protein localization to synapse (GO:0035418) | 3.44251477 |
| 31 | neuron cell-cell adhesion (GO:0007158) | 3.41720520 |
| 32 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.30587815 |
| 33 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.27784665 |
| 34 | vesicle transport along microtubule (GO:0047496) | 3.24909083 |
| 35 | protein localization to endosome (GO:0036010) | 3.18310403 |
| 36 | cerebellar Purkinje cell layer development (GO:0021680) | 3.18146082 |
| 37 | detection of calcium ion (GO:0005513) | 3.17872936 |
| 38 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.16124667 |
| 39 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.15660315 |
| 40 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.13392710 |
| 41 | neurotransmitter transport (GO:0006836) | 3.10374262 |
| 42 | neuromuscular process controlling posture (GO:0050884) | 3.09934068 |
| 43 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.04486298 |
| 44 | regulation of neurotransmitter secretion (GO:0046928) | 3.02783583 |
| 45 | regulation of vesicle fusion (GO:0031338) | 3.01674638 |
| 46 | positive regulation of synapse maturation (GO:0090129) | 3.00192984 |
| 47 | innervation (GO:0060384) | 2.98781017 |
| 48 | neurotransmitter-gated ion channel clustering (GO:0072578) | 2.98118953 |
| 49 | membrane repolarization during cardiac muscle cell action potential (GO:0086013) | 2.97935591 |
| 50 | membrane depolarization during action potential (GO:0086010) | 2.96719690 |
| 51 | negative regulation of complement activation (GO:0045916) | 2.94409560 |
| 52 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 2.93700567 |
| 53 | membrane repolarization (GO:0086009) | 2.92318269 |
| 54 | organelle transport along microtubule (GO:0072384) | 2.91841329 |
| 55 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 2.91443355 |
| 56 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 2.91074729 |
| 57 | response to pheromone (GO:0019236) | 2.90812088 |
| 58 | macroautophagy (GO:0016236) | 2.90271400 |
| 59 | glycine transport (GO:0015816) | 2.87977643 |
| 60 | synaptic transmission, glutamatergic (GO:0035249) | 2.87951202 |
| 61 | regulation of ARF protein signal transduction (GO:0032012) | 2.87302835 |
| 62 | neuron-neuron synaptic transmission (GO:0007270) | 2.86021854 |
| 63 | potassium ion import (GO:0010107) | 2.85840550 |
| 64 | regulation of neurotransmitter levels (GO:0001505) | 2.84232417 |
| 65 | long-term memory (GO:0007616) | 2.83704369 |
| 66 | synaptic vesicle endocytosis (GO:0048488) | 2.82828739 |
| 67 | gamma-aminobutyric acid transport (GO:0015812) | 2.81648536 |
| 68 | long-term synaptic potentiation (GO:0060291) | 2.81612208 |
| 69 | regulation of synaptic plasticity (GO:0048167) | 2.81510541 |
| 70 | regulation of neurotransmitter transport (GO:0051588) | 2.80825054 |
| 71 | dendrite morphogenesis (GO:0048813) | 2.80576487 |
| 72 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 2.80571184 |
| 73 | negative regulation of humoral immune response (GO:0002921) | 2.79819021 |
| 74 | nerve growth factor signaling pathway (GO:0038180) | 2.79339625 |
| 75 | negative regulation of microtubule polymerization (GO:0031115) | 2.77723245 |
| 76 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 2.77380660 |
| 77 | positive regulation of membrane potential (GO:0045838) | 2.76709587 |
| 78 | neuromuscular process controlling balance (GO:0050885) | 2.76529882 |
| 79 | negative regulation of protein activation cascade (GO:2000258) | 2.76421025 |
| 80 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 2.74567827 |
| 81 | positive regulation of potassium ion transport (GO:0043268) | 2.74182993 |
| 82 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 2.73304448 |
| 83 | cellular response to monoamine stimulus (GO:0071868) | 2.72761227 |
| 84 | cellular response to catecholamine stimulus (GO:0071870) | 2.72761227 |
| 85 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 2.70422605 |
| 86 | cell communication involved in cardiac conduction (GO:0086065) | 2.70335674 |
| 87 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 2.70020704 |
| 88 | mating behavior (GO:0007617) | 2.68393077 |
| 89 | positive regulation of vesicle fusion (GO:0031340) | 2.68342842 |
| 90 | axon cargo transport (GO:0008088) | 2.68191856 |
| 91 | insulin secretion (GO:0030073) | 2.67644389 |
| 92 | regulation of postsynaptic membrane potential (GO:0060078) | 2.66931008 |
| 93 | regulation of calcium ion-dependent exocytosis (GO:0017158) | 2.66615545 |
| 94 | dendritic spine morphogenesis (GO:0060997) | 2.65979529 |
| 95 | membrane repolarization during action potential (GO:0086011) | 2.65537782 |
| 96 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 2.64999606 |
| 97 | regulation of cell communication by electrical coupling (GO:0010649) | 2.64617800 |
| 98 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 2.64454780 |
| 99 | neuron recognition (GO:0008038) | 2.64423598 |
| 100 | signal release (GO:0023061) | 2.63553283 |
| 101 | regulation of membrane repolarization (GO:0060306) | 2.61743996 |
| 102 | cellular sodium ion homeostasis (GO:0006883) | 2.61701686 |
| 103 | potassium ion homeostasis (GO:0055075) | 2.61519755 |
| 104 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.60627455 |
| 105 | suckling behavior (GO:0001967) | 2.60445310 |
| 106 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 2.58229360 |
| 107 | response to catecholamine (GO:0071869) | 2.57649148 |
| 108 | response to monoamine (GO:0071867) | 2.57649148 |
| 109 | glutamate receptor signaling pathway (GO:0007215) | 2.56766107 |
| 110 | postsynaptic membrane organization (GO:0001941) | 2.56686324 |
| 111 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 2.55709791 |
| 112 | regulation of calcium ion transmembrane transport (GO:1903169) | 2.55709791 |
| 113 | positive regulation of neurotransmitter transport (GO:0051590) | 2.55120262 |
| 114 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 2.50842680 |
| 115 | cellular response to epinephrine stimulus (GO:0071872) | 2.49805299 |
| 116 | positive regulation of receptor recycling (GO:0001921) | 2.48139300 |
| 117 | regulation of beta-amyloid formation (GO:1902003) | 2.44014807 |
| 118 | response to epinephrine (GO:0071871) | 2.37729291 |
| 119 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 2.36144576 |
| 120 | axonemal dynein complex assembly (GO:0070286) | 2.33516336 |
| 121 | Golgi to endosome transport (GO:0006895) | 2.30687838 |
| 122 | clathrin coat assembly (GO:0048268) | 2.28656012 |
| 123 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 2.28549836 |
| 124 | cilium or flagellum-dependent cell motility (GO:0001539) | 2.27487449 |
| 125 | vesicle coating (GO:0006901) | 2.24527306 |
| 126 | establishment of nucleus localization (GO:0040023) | 2.24104357 |
| 127 | cellular response to prostaglandin stimulus (GO:0071379) | 2.23009505 |
| 128 | positive regulation of phosphoprotein phosphatase activity (GO:0032516) | 2.22960419 |
| 129 | regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315) | 2.21686868 |
| 130 | relaxation of cardiac muscle (GO:0055119) | 2.19644673 |
| 131 | surfactant homeostasis (GO:0043129) | 2.17016361 |
| 132 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 2.16639058 |
| 133 | growth hormone receptor signaling pathway (GO:0060396) | 2.16351443 |
| 134 | regulation of actin filament-based movement (GO:1903115) | 2.14278332 |
| 135 | regulation of cardiac muscle cell contraction (GO:0086004) | 2.14066191 |
| 136 | cellular response to growth hormone stimulus (GO:0071378) | 2.13140614 |
| 137 | regulation of amyloid precursor protein catabolic process (GO:1902991) | 2.12738842 |
| 138 | cerebellar granule cell differentiation (GO:0021707) | 2.12242956 |
| 139 | Golgi to plasma membrane protein transport (GO:0043001) | 2.11645815 |
| 140 | negative regulation of immunoglobulin mediated immune response (GO:0002890) | 2.06619663 |
| 141 | negative regulation of B cell mediated immunity (GO:0002713) | 2.06619663 |
| 142 | cell adhesion mediated by integrin (GO:0033627) | 2.03975689 |
| 143 | Golgi to plasma membrane transport (GO:0006893) | 2.03439531 |
| 144 | regulation of receptor recycling (GO:0001919) | 2.01149388 |
| 145 | regulation of clathrin-mediated endocytosis (GO:2000369) | 2.00766125 |
| 146 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 2.00347166 |
| 147 | cellular response to antibiotic (GO:0071236) | 1.97991202 |
| 148 | iron ion import (GO:0097286) | 1.97440655 |
| 149 | positive regulation of cardiac muscle hypertrophy (GO:0010613) | 1.96110142 |
| 150 | positive regulation of muscle hypertrophy (GO:0014742) | 1.96110142 |
| 151 | negative regulation of protein localization to plasma membrane (GO:1903077) | 1.95716652 |
| 152 | import into cell (GO:0098657) | 1.94029900 |
| 153 | neurological system process involved in regulation of systemic arterial blood pressure (GO:0001976) | 1.93917427 |
| 154 | polyol transport (GO:0015791) | 1.91606624 |
| 155 | cardiac muscle contraction (GO:0060048) | 1.91490572 |
| 156 | positive regulation of insulin receptor signaling pathway (GO:0046628) | 1.90648037 |
| 157 | regulation of complement activation (GO:0030449) | 1.88735777 |
| 158 | positive regulation of cellular amide metabolic process (GO:0034250) | 1.88202777 |
| 159 | embryonic retina morphogenesis in camera-type eye (GO:0060059) | 1.86633034 |
| 160 | negative regulation of neurotransmitter secretion (GO:0046929) | 1.86483559 |
| 161 | COPII vesicle coating (GO:0048208) | 1.85817603 |
| 162 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 1.85450125 |
| 163 | regulation of steroid hormone biosynthetic process (GO:0090030) | 1.84625913 |
| 164 | cilium movement (GO:0003341) | 1.83484627 |
| 165 | adenylate cyclase-activating dopamine receptor signaling pathway (GO:0007191) | 1.83281650 |
| 166 | phosphatidylinositol dephosphorylation (GO:0046856) | 1.81164312 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.06770036 |
| 2 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.93030636 |
| 3 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.90409031 |
| 4 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.81507622 |
| 5 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.63968366 |
| 6 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.59157579 |
| 7 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.53421946 |
| 8 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.51287704 |
| 9 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.50057397 |
| 10 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.48323614 |
| 11 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.48007256 |
| 12 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.48007256 |
| 13 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.45755565 |
| 14 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.42775279 |
| 15 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.36732711 |
| 16 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.36018631 |
| 17 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.25507517 |
| 18 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.14719723 |
| 19 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.12041797 |
| 20 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.11410276 |
| 21 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.07242215 |
| 22 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.03518645 |
| 23 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 2.00598474 |
| 24 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.98361615 |
| 25 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.94753721 |
| 26 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.94470091 |
| 27 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.93813168 |
| 28 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.92069719 |
| 29 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.90802724 |
| 30 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.89785929 |
| 31 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.89273974 |
| 32 | * CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.88954352 |
| 33 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.86596981 |
| 34 | * POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.85169508 |
| 35 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.84473621 |
| 36 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.79987432 |
| 37 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.71529917 |
| 38 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.71529917 |
| 39 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.58658389 |
| 40 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.54781275 |
| 41 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.53695829 |
| 42 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.53336752 |
| 43 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.51689886 |
| 44 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.51273580 |
| 45 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.49112532 |
| 46 | * ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.47620651 |
| 47 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.47299815 |
| 48 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.45087935 |
| 49 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.44983598 |
| 50 | * WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.42418558 |
| 51 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.39829345 |
| 52 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.39519150 |
| 53 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.38805663 |
| 54 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.36648798 |
| 55 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.35838030 |
| 56 | TP53_16413492_ChIP-PET_HCT116_Human | 1.35306378 |
| 57 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.34436199 |
| 58 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.34105225 |
| 59 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.33420239 |
| 60 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.32592391 |
| 61 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.30305231 |
| 62 | KDM2B_26808549_Chip-Seq_K562_Human | 1.30015602 |
| 63 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.29507927 |
| 64 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.29485366 |
| 65 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.27755287 |
| 66 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.27407112 |
| 67 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.26600907 |
| 68 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.25761387 |
| 69 | AR_19668381_ChIP-Seq_PC3_Human | 1.24463068 |
| 70 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.23648628 |
| 71 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.23539992 |
| 72 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.22845228 |
| 73 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.20534079 |
| 74 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.19875994 |
| 75 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.19688833 |
| 76 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 1.19567614 |
| 77 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.19054727 |
| 78 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.18788478 |
| 79 | STAT3_23295773_ChIP-Seq_U87_Human | 1.18025100 |
| 80 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.17944347 |
| 81 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.17156089 |
| 82 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.15659687 |
| 83 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.13648085 |
| 84 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.12760210 |
| 85 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.12700667 |
| 86 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.12389683 |
| 87 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.11960578 |
| 88 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.11379033 |
| 89 | CJUN_26792858_Chip-Seq_BT549_Human | 1.10989878 |
| 90 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.10378542 |
| 91 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.10075202 |
| 92 | AR_25329375_ChIP-Seq_VCAP_Human | 1.08920730 |
| 93 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.08600127 |
| 94 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.08211095 |
| 95 | * YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.07770758 |
| 96 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.07715651 |
| 97 | * TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.07207064 |
| 98 | * TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.07207064 |
| 99 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.05625975 |
| 100 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 1.05049895 |
| 101 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.04242428 |
| 102 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.03680274 |
| 103 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 1.03378055 |
| 104 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.01911973 |
| 105 | TP63_23658742_ChIP-Seq_EP156T_Human | 1.01677156 |
| 106 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 1.01395988 |
| 107 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.00967836 |
| 108 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.99658735 |
| 109 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.99444286 |
| 110 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.99096659 |
| 111 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.98962052 |
| 112 | * P300_19829295_ChIP-Seq_ESCs_Human | 0.98592580 |
| 113 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.98581374 |
| 114 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.98213473 |
| 115 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.97875963 |
| 116 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.97585260 |
| 117 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.97541800 |
| 118 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.97105388 |
| 119 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 0.97033558 |
| 120 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.96553038 |
| 121 | TCF4_23295773_ChIP-Seq_U87_Human | 0.96291275 |
| 122 | P53_22387025_ChIP-Seq_ESCs_Mouse | 0.95969218 |
| 123 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 0.95078589 |
| 124 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.95045121 |
| 125 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.94771836 |
| 126 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.94757029 |
| 127 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.94587709 |
| 128 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 0.94180070 |
| 129 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.93948821 |
| 130 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.93220748 |
| 131 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.93061940 |
| 132 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.92405707 |
| 133 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.90458753 |
| 134 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.89883298 |
| 135 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.89416735 |
| 136 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.89326874 |
| 137 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.89060897 |
| 138 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.88607572 |
| 139 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 0.87012288 |
| 140 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.86849290 |
| 141 | RXR_22108803_ChIP-Seq_LS180_Human | 0.82926605 |
| 142 | * ZFP281_27345836_Chip-Seq_ESCs_Mouse | 0.82104034 |
| 143 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.82081242 |
| 144 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 0.81900655 |
| 145 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.81705510 |
| 146 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.81530764 |
| 147 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.81106688 |
| 148 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.81106316 |
| 149 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.80463206 |
| 150 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.80177355 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 5.45489794 |
| 2 | MP0003635_abnormal_synaptic_transmissio | 3.62407346 |
| 3 | MP0003880_abnormal_central_pattern | 3.41294447 |
| 4 | MP0004270_analgesia | 3.39156917 |
| 5 | MP0009780_abnormal_chondrocyte_physiolo | 3.00350825 |
| 6 | MP0002063_abnormal_learning/memory/cond | 2.80130271 |
| 7 | MP0009745_abnormal_behavioral_response | 2.75147359 |
| 8 | MP0002064_seizures | 2.66166220 |
| 9 | MP0001968_abnormal_touch/_nociception | 2.55966824 |
| 10 | MP0010234_abnormal_vibrissa_follicle | 2.52771300 |
| 11 | MP0009046_muscle_twitch | 2.44691843 |
| 12 | MP0002734_abnormal_mechanical_nocicepti | 2.42556262 |
| 13 | * MP0002909_abnormal_adrenal_gland | 2.36758214 |
| 14 | MP0003122_maternal_imprinting | 2.34992162 |
| 15 | MP0002572_abnormal_emotion/affect_behav | 2.32283361 |
| 16 | MP0005248_abnormal_Harderian_gland | 2.28248415 |
| 17 | MP0002837_dystrophic_cardiac_calcinosis | 2.28066875 |
| 18 | MP0002822_catalepsy | 2.26847081 |
| 19 | MP0002272_abnormal_nervous_system | 2.17925566 |
| 20 | MP0004858_abnormal_nervous_system | 2.13931214 |
| 21 | MP0002735_abnormal_chemical_nociception | 2.10522361 |
| 22 | MP0003690_abnormal_glial_cell | 2.06291502 |
| 23 | MP0002733_abnormal_thermal_nociception | 2.01940824 |
| 24 | MP0005423_abnormal_somatic_nervous | 1.98521279 |
| 25 | MP0004272_abnormal_basement_membrane | 1.97770709 |
| 26 | MP0001970_abnormal_pain_threshold | 1.90420237 |
| 27 | MP0000751_myopathy | 1.89687659 |
| 28 | MP0008569_lethality_at_weaning | 1.89493354 |
| 29 | MP0005409_darkened_coat_color | 1.87767489 |
| 30 | MP0001501_abnormal_sleep_pattern | 1.86735132 |
| 31 | MP0008438_abnormal_cutaneous_collagen | 1.85335742 |
| 32 | MP0002736_abnormal_nociception_after | 1.85263651 |
| 33 | MP0004811_abnormal_neuron_physiology | 1.80085925 |
| 34 | MP0003566_abnormal_cell_adhesion | 1.76010930 |
| 35 | MP0003329_amyloid_beta_deposits | 1.73525023 |
| 36 | MP0005645_abnormal_hypothalamus_physiol | 1.71683915 |
| 37 | MP0001486_abnormal_startle_reflex | 1.71606145 |
| 38 | MP0002067_abnormal_sensory_capabilities | 1.71434165 |
| 39 | MP0010386_abnormal_urinary_bladder | 1.71285901 |
| 40 | MP0005646_abnormal_pituitary_gland | 1.70954542 |
| 41 | MP0002184_abnormal_innervation | 1.70950012 |
| 42 | MP0003283_abnormal_digestive_organ | 1.68732012 |
| 43 | MP0001958_emphysema | 1.67487314 |
| 44 | MP0003183_abnormal_peptide_metabolism | 1.64740089 |
| 45 | MP0008961_abnormal_basal_metabolism | 1.64090646 |
| 46 | MP0006276_abnormal_autonomic_nervous | 1.63623121 |
| 47 | MP0003300_gastrointestinal_ulcer | 1.60436379 |
| 48 | MP0003191_abnormal_cellular_cholesterol | 1.59135949 |
| 49 | MP0001440_abnormal_grooming_behavior | 1.58948358 |
| 50 | MP0003724_increased_susceptibility_to | 1.58497526 |
| 51 | MP0003787_abnormal_imprinting | 1.54898445 |
| 52 | MP0003632_abnormal_nervous_system | 1.53787553 |
| 53 | MP0004924_abnormal_behavior | 1.52957613 |
| 54 | MP0005386_behavior/neurological_phenoty | 1.52957613 |
| 55 | * MP0003091_abnormal_cell_migration | 1.52733588 |
| 56 | MP0002557_abnormal_social/conspecific_i | 1.52203666 |
| 57 | MP0003879_abnormal_hair_cell | 1.51625188 |
| 58 | * MP0000013_abnormal_adipose_tissue | 1.48968824 |
| 59 | MP0003221_abnormal_cardiomyocyte_apopto | 1.48886699 |
| 60 | MP0001502_abnormal_circadian_rhythm | 1.48525669 |
| 61 | MP0000955_abnormal_spinal_cord | 1.48081261 |
| 62 | MP0008260_abnormal_autophagy | 1.48006427 |
| 63 | MP0003828_pulmonary_edema | 1.47565129 |
| 64 | MP0010678_abnormal_skin_adnexa | 1.45105254 |
| 65 | MP0002009_preneoplasia | 1.43192323 |
| 66 | MP0000920_abnormal_myelination | 1.38053006 |
| 67 | MP0003633_abnormal_nervous_system | 1.36195775 |
| 68 | MP0004215_abnormal_myocardial_fiber | 1.34008667 |
| 69 | MP0004084_abnormal_cardiac_muscle | 1.33941322 |
| 70 | MP0006054_spinal_hemorrhage | 1.33428041 |
| 71 | MP0001984_abnormal_olfaction | 1.29480503 |
| 72 | MP0004043_abnormal_pH_regulation | 1.28021772 |
| 73 | MP0002877_abnormal_melanocyte_morpholog | 1.26104380 |
| 74 | MP0004233_abnormal_muscle_weight | 1.23967757 |
| 75 | MP0002066_abnormal_motor_capabilities/c | 1.23595465 |
| 76 | MP0000778_abnormal_nervous_system | 1.21595900 |
| 77 | MP0002882_abnormal_neuron_morphology | 1.20900684 |
| 78 | MP0004885_abnormal_endolymph | 1.20146371 |
| 79 | MP0008004_abnormal_stomach_pH | 1.19406040 |
| 80 | MP0004145_abnormal_muscle_electrophysio | 1.19210477 |
| 81 | MP0005408_hypopigmentation | 1.18343642 |
| 82 | MP0002332_abnormal_exercise_endurance | 1.18256059 |
| 83 | MP0003656_abnormal_erythrocyte_physiolo | 1.17443535 |
| 84 | MP0005167_abnormal_blood-brain_barrier | 1.15434541 |
| 85 | MP0004036_abnormal_muscle_relaxation | 1.14767505 |
| 86 | MP0004883_abnormal_blood_vessel | 1.14190099 |
| 87 | MP0005058_abnormal_lysosome_morphology | 1.12665004 |
| 88 | MP0000465_gastrointestinal_hemorrhage | 1.12549894 |
| 89 | MP0001299_abnormal_eye_distance/ | 1.11405662 |
| 90 | MP0001915_intracranial_hemorrhage | 1.10254157 |
| 91 | MP0002133_abnormal_respiratory_system | 1.09906049 |
| 92 | MP0005388_respiratory_system_phenotype | 1.09906049 |
| 93 | * MP0004085_abnormal_heartbeat | 1.09360119 |
| 94 | MP0006138_congestive_heart_failure | 1.08872164 |
| 95 | MP0005171_absent_coat_pigmentation | 1.08179250 |
| 96 | MP0005164_abnormal_response_to | 1.05795211 |
| 97 | MP0005623_abnormal_meninges_morphology | 1.04170108 |
| 98 | MP0005257_abnormal_intraocular_pressure | 1.01613655 |
| 99 | MP0005165_increased_susceptibility_to | 1.01020832 |
| 100 | MP0005275_abnormal_skin_tensile | 1.00870052 |
| 101 | MP0003172_abnormal_lysosome_physiology | 0.99370684 |
| 102 | MP0003631_nervous_system_phenotype | 0.97505154 |
| 103 | MP0002638_abnormal_pupillary_reflex | 0.97239552 |
| 104 | MP0001177_atelectasis | 0.95470647 |
| 105 | MP0002693_abnormal_pancreas_physiology | 0.94240795 |
| 106 | MP0001944_abnormal_pancreas_morphology | 0.93889013 |
| 107 | MP0000747_muscle_weakness | 0.92131947 |
| 108 | MP0010368_abnormal_lymphatic_system | 0.91830706 |
| 109 | MP0002069_abnormal_eating/drinking_beha | 0.90334854 |
| 110 | MP0004510_myositis | 0.90258215 |
| 111 | MP0005535_abnormal_body_temperature | 0.89530204 |
| 112 | MP0004130_abnormal_muscle_cell | 0.89335879 |
| 113 | MP0003634_abnormal_glial_cell | 0.89316805 |
| 114 | MP0001905_abnormal_dopamine_level | 0.88954604 |
| 115 | MP0000383_abnormal_hair_follicle | 0.88832687 |
| 116 | MP0010630_abnormal_cardiac_muscle | 0.87806718 |
| 117 | MP0002971_abnormal_brown_adipose | 0.85401553 |
| 118 | MP0002152_abnormal_brain_morphology | 0.85195163 |
| 119 | MP0000569_abnormal_digit_pigmentation | 0.84714768 |
| 120 | MP0001879_abnormal_lymphatic_vessel | 0.84232288 |
| 121 | * MP0002896_abnormal_bone_mineralization | 0.83970517 |
| 122 | MP0002234_abnormal_pharynx_morphology | 0.82497557 |
| 123 | MP0001348_abnormal_lacrimal_gland | 0.81894614 |
| 124 | MP0002229_neurodegeneration | 0.81717132 |
| 125 | MP0002972_abnormal_cardiac_muscle | 0.80990131 |
| 126 | MP0003137_abnormal_impulse_conducting | 0.80822218 |
| 127 | MP0002090_abnormal_vision | 0.80428900 |
| 128 | MP0002078_abnormal_glucose_homeostasis | 0.80163188 |
| 129 | MP0003115_abnormal_respiratory_system | 0.78256376 |
| 130 | MP0006072_abnormal_retinal_apoptosis | 0.78157471 |
| 131 | MP0004484_altered_response_of | 0.77888229 |
| 132 | MP0003045_fibrosis | 0.77664098 |
| 133 | MP0000749_muscle_degeneration | 0.76975168 |
| 134 | MP0001529_abnormal_vocalization | 0.76919025 |
| 135 | MP0001851_eye_inflammation | 0.76148533 |
| 136 | MP0005330_cardiomyopathy | 0.75267913 |
| 137 | MP0001544_abnormal_cardiovascular_syste | 0.74926123 |
| 138 | MP0005385_cardiovascular_system_phenoty | 0.74926123 |
| 139 | MP0005620_abnormal_muscle_contractility | 0.72847004 |
| 140 | MP0000631_abnormal_neuroendocrine_gland | 0.71924601 |
| 141 | * MP0002269_muscular_atrophy | 0.71316936 |
| 142 | MP0004142_abnormal_muscle_tone | 0.69386593 |
| 143 | MP0005187_abnormal_penis_morphology | 0.68553586 |
| 144 | MP0000604_amyloidosis | 0.65572840 |
| 145 | MP0005379_endocrine/exocrine_gland_phen | 0.64242378 |
| 146 | MP0002751_abnormal_autonomic_nervous | 0.63163478 |
| 147 | MP0003123_paternal_imprinting | 0.63062038 |
| 148 | * MP0000003_abnormal_adipose_tissue | 0.61189237 |
| 149 | MP0000534_abnormal_ureter_morphology | 0.60456974 |
| 150 | MP0004087_abnormal_muscle_fiber | 0.59459560 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 5.13675185 |
| 2 | Myokymia (HP:0002411) | 4.81905073 |
| 3 | Visual hallucinations (HP:0002367) | 4.58116736 |
| 4 | Focal seizures (HP:0007359) | 4.22759996 |
| 5 | Atonic seizures (HP:0010819) | 4.11327472 |
| 6 | Epileptic encephalopathy (HP:0200134) | 3.65629916 |
| 7 | Action tremor (HP:0002345) | 3.49901215 |
| 8 | Papilledema (HP:0001085) | 3.39238015 |
| 9 | Absence seizures (HP:0002121) | 3.35908326 |
| 10 | Progressive cerebellar ataxia (HP:0002073) | 3.31322744 |
| 11 | Febrile seizures (HP:0002373) | 3.23847287 |
| 12 | Ankle clonus (HP:0011448) | 3.22381797 |
| 13 | Supranuclear gaze palsy (HP:0000605) | 3.20345670 |
| 14 | * Depression (HP:0000716) | 3.05036276 |
| 15 | Truncal ataxia (HP:0002078) | 2.99069883 |
| 16 | Generalized tonic-clonic seizures (HP:0002069) | 2.97876500 |
| 17 | Arterial tortuosity (HP:0005116) | 2.91660911 |
| 18 | Dialeptic seizures (HP:0011146) | 2.88496279 |
| 19 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 2.84036196 |
| 20 | Neurofibrillary tangles (HP:0002185) | 2.82156749 |
| 21 | Ventricular fibrillation (HP:0001663) | 2.69066971 |
| 22 | * Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.66358240 |
| 23 | Vascular tortuosity (HP:0004948) | 2.65555622 |
| 24 | Failure to thrive in infancy (HP:0001531) | 2.65363886 |
| 25 | * Pheochromocytoma (HP:0002666) | 2.60813388 |
| 26 | Poor eye contact (HP:0000817) | 2.60421445 |
| 27 | Hypoventilation (HP:0002791) | 2.58751241 |
| 28 | * Anxiety (HP:0000739) | 2.56569222 |
| 29 | Abnormal respiratory motile cilium morphology (HP:0005938) | 2.49117725 |
| 30 | Abnormal respiratory epithelium morphology (HP:0012253) | 2.49117725 |
| 31 | Bundle branch block (HP:0011710) | 2.47988803 |
| 32 | Rhinitis (HP:0012384) | 2.47090433 |
| 33 | Epileptiform EEG discharges (HP:0011182) | 2.46039923 |
| 34 | Dysmetric saccades (HP:0000641) | 2.45980328 |
| 35 | Limb dystonia (HP:0002451) | 2.44363538 |
| 36 | Hyporeflexia of lower limbs (HP:0002600) | 2.44217967 |
| 37 | EEG with generalized epileptiform discharges (HP:0011198) | 2.44044773 |
| 38 | Abnormal eating behavior (HP:0100738) | 2.42233568 |
| 39 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.41778665 |
| 40 | Impaired social interactions (HP:0000735) | 2.39696656 |
| 41 | Abnormal social behavior (HP:0012433) | 2.39696656 |
| 42 | Macroorchidism (HP:0000053) | 2.38491537 |
| 43 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 2.38454249 |
| 44 | Impaired smooth pursuit (HP:0007772) | 2.37910981 |
| 45 | Postural instability (HP:0002172) | 2.37023473 |
| 46 | Hypsarrhythmia (HP:0002521) | 2.35151625 |
| 47 | Urinary urgency (HP:0000012) | 2.34258375 |
| 48 | * Papillary thyroid carcinoma (HP:0002895) | 2.33852363 |
| 49 | Abnormal respiratory motile cilium physiology (HP:0012261) | 2.33203543 |
| 50 | Abnormal ciliary motility (HP:0012262) | 2.32219988 |
| 51 | Postural tremor (HP:0002174) | 2.30736949 |
| 52 | Genetic anticipation (HP:0003743) | 2.30390304 |
| 53 | Interstitial pulmonary disease (HP:0006530) | 2.29185555 |
| 54 | Resting tremor (HP:0002322) | 2.28882912 |
| 55 | Abnormality of the lower motor neuron (HP:0002366) | 2.28790841 |
| 56 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.27913435 |
| 57 | Heterochromia iridis (HP:0001100) | 2.27697800 |
| 58 | Dysdiadochokinesis (HP:0002075) | 2.26662963 |
| 59 | Prolonged QT interval (HP:0001657) | 2.26630072 |
| 60 | Torticollis (HP:0000473) | 2.24210784 |
| 61 | * Neuroendocrine neoplasm (HP:0100634) | 2.23077486 |
| 62 | * Hypercortisolism (HP:0001578) | 2.22703365 |
| 63 | Amblyopia (HP:0000646) | 2.20662102 |
| 64 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.19487084 |
| 65 | Absent/shortened dynein arms (HP:0200106) | 2.19487084 |
| 66 | Insidious onset (HP:0003587) | 2.17491749 |
| 67 | Termporal pattern (HP:0011008) | 2.17491749 |
| 68 | Broad-based gait (HP:0002136) | 2.15855081 |
| 69 | Absent frontal sinuses (HP:0002688) | 2.15254917 |
| 70 | Sudden death (HP:0001699) | 2.14972728 |
| 71 | Insomnia (HP:0100785) | 2.14312432 |
| 72 | Abnormal EKG (HP:0003115) | 2.13621050 |
| 73 | Gaze-evoked nystagmus (HP:0000640) | 2.12928273 |
| 74 | Cerebral aneurysm (HP:0004944) | 2.12903566 |
| 75 | Dysmetria (HP:0001310) | 2.11880151 |
| 76 | Hyperventilation (HP:0002883) | 2.10707172 |
| 77 | Bradykinesia (HP:0002067) | 2.09307758 |
| 78 | Impaired pain sensation (HP:0007328) | 2.06723868 |
| 79 | Abnormality of pain sensation (HP:0010832) | 2.06723868 |
| 80 | Hemiplegia (HP:0002301) | 2.04462047 |
| 81 | Focal dystonia (HP:0004373) | 2.03611912 |
| 82 | * Agitation (HP:0000713) | 2.02088966 |
| 83 | Mutism (HP:0002300) | 2.01333521 |
| 84 | Subaortic stenosis (HP:0001682) | 2.00489176 |
| 85 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.00489176 |
| 86 | Difficulty running (HP:0009046) | 2.00185074 |
| 87 | Abnormality of binocular vision (HP:0011514) | 2.00065828 |
| 88 | Diplopia (HP:0000651) | 2.00065828 |
| 89 | Abnormality of ocular smooth pursuit (HP:0000617) | 1.99903741 |
| 90 | Abnormality of the corticospinal tract (HP:0002492) | 1.99578082 |
| 91 | Megalencephaly (HP:0001355) | 1.99530471 |
| 92 | Asymmetric septal hypertrophy (HP:0001670) | 1.99125796 |
| 93 | Subacute progressive viral hepatitis (HP:0006572) | 1.98957447 |
| 94 | Atrioventricular block (HP:0001678) | 1.98760309 |
| 95 | Rapidly progressive (HP:0003678) | 1.98627790 |
| 96 | Muscle fiber splitting (HP:0003555) | 1.98591090 |
| 97 | Intention tremor (HP:0002080) | 1.98206806 |
| 98 | Progressive inability to walk (HP:0002505) | 1.98171500 |
| 99 | Asymmetry of the thorax (HP:0001555) | 1.95806717 |
| 100 | Tetraparesis (HP:0002273) | 1.94563858 |
| 101 | Scanning speech (HP:0002168) | 1.94112684 |
| 102 | Spastic gait (HP:0002064) | 1.93830643 |
| 103 | Pointed chin (HP:0000307) | 1.93786138 |
| 104 | Excessive salivation (HP:0003781) | 1.92218572 |
| 105 | Drooling (HP:0002307) | 1.92218572 |
| 106 | Hammertoe (HP:0001765) | 1.92098177 |
| 107 | Hand muscle atrophy (HP:0009130) | 1.92083410 |
| 108 | Skin nodule (HP:0200036) | 1.90683025 |
| 109 | Right ventricular cardiomyopathy (HP:0011663) | 1.89767184 |
| 110 | Myotonia (HP:0002486) | 1.88840525 |
| 111 | Hyperparathyroidism (HP:0000843) | 1.88239203 |
| 112 | Decreased number of peripheral myelinated nerve fibers (HP:0003380) | 1.87760458 |
| 113 | Craniofacial dystonia (HP:0012179) | 1.87546945 |
| 114 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.87269591 |
| 115 | Fetal akinesia sequence (HP:0001989) | 1.85854694 |
| 116 | Stereotypic behavior (HP:0000733) | 1.85187874 |
| 117 | Gait ataxia (HP:0002066) | 1.85121549 |
| 118 | Abnormality of the common coagulation pathway (HP:0010990) | 1.84372379 |
| 119 | Lower limb muscle weakness (HP:0007340) | 1.83474716 |
| 120 | Syncope (HP:0001279) | 1.83460892 |
| 121 | Hemiparesis (HP:0001269) | 1.83380882 |
| 122 | * Abnormality of calcium-phosphate metabolism (HP:0100530) | 1.82821461 |
| 123 | Abnormality of the foot musculature (HP:0001436) | 1.80884311 |
| 124 | Decreased motor nerve conduction velocity (HP:0003431) | 1.80313211 |
| 125 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 1.80296489 |
| 126 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 1.80296489 |
| 127 | Autoamputation (HP:0001218) | 1.79169929 |
| 128 | Exercise-induced myalgia (HP:0003738) | 1.78590233 |
| 129 | Foot dorsiflexor weakness (HP:0009027) | 1.78164320 |
| 130 | Cerebral inclusion bodies (HP:0100314) | 1.77137184 |
| 131 | Enlarged penis (HP:0000040) | 1.74859084 |
| 132 | Heart block (HP:0012722) | 1.74453948 |
| 133 | Protrusio acetabuli (HP:0003179) | 1.74363846 |
| 134 | Abnormal atrioventricular conduction (HP:0005150) | 1.74191465 |
| 135 | Rigidity (HP:0002063) | 1.73644842 |
| 136 | Limb-girdle muscle atrophy (HP:0003797) | 1.73058105 |
| 137 | Central scotoma (HP:0000603) | 1.72851876 |
| 138 | Amyotrophic lateral sclerosis (HP:0007354) | 1.72563903 |
| 139 | Upper limb amyotrophy (HP:0009129) | 1.72273222 |
| 140 | Distal upper limb amyotrophy (HP:0007149) | 1.72273222 |
| 141 | Abnormality of the calf musculature (HP:0001430) | 1.72053244 |
| 142 | Exercise-induced muscle cramps (HP:0003710) | 1.71354515 |
| 143 | Male infertility (HP:0003251) | 1.71031332 |
| 144 | Ventricular arrhythmia (HP:0004308) | 1.70485954 |
| 145 | Abnormality of the hip-girdle musculature (HP:0001445) | 1.69904797 |
| 146 | Abnormality of the musculature of the pelvis (HP:0001469) | 1.69904797 |
| 147 | Deep venous thrombosis (HP:0002625) | 1.69551089 |
| 148 | Clonus (HP:0002169) | 1.68881491 |
| 149 | Shoulder girdle muscle weakness (HP:0003547) | 1.68836621 |
| 150 | Aplasia/Hypoplasia of the frontal sinuses (HP:0009119) | 1.68300320 |
| 151 | Atrial fibrillation (HP:0005110) | 1.67958449 |
| 152 | Distal lower limb amyotrophy (HP:0008944) | 1.67853585 |
| 153 | * Neoplasm of the peripheral nervous system (HP:0100007) | 1.67535370 |
| 154 | Distal lower limb muscle weakness (HP:0009053) | 1.67303347 |
| 155 | Primary atrial arrhythmia (HP:0001692) | 1.67049987 |
| 156 | Decreased circulating renin level (HP:0003351) | 1.66773394 |
| 157 | * Thyroid carcinoma (HP:0002890) | 1.66755056 |
| 158 | * Blue irides (HP:0000635) | 1.66316179 |
| 159 | Ventricular tachycardia (HP:0004756) | 1.65966194 |
| 160 | Mucopolysacchariduria (HP:0008155) | 1.65776887 |
| 161 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.65776887 |
| 162 | Frequent falls (HP:0002359) | 1.65351061 |
| 163 | Hyperthyroidism (HP:0000836) | 1.64918750 |
| 164 | Ankyloglossia (HP:0010296) | 1.64886377 |
| 165 | Lower limb amyotrophy (HP:0007210) | 1.64286441 |
| 166 | Gingival bleeding (HP:0000225) | 1.62880494 |
| 167 | Orthostatic hypotension (HP:0001278) | 1.62420568 |
| 168 | Hypoplasia of the iris (HP:0007676) | 1.61119331 |
| 169 | Flat acetabular roof (HP:0003180) | 1.60464377 |
| 170 | Menorrhagia (HP:0000132) | 1.59902990 |
| 171 | EMG: myopathic abnormalities (HP:0003458) | 1.59899539 |
| 172 | Difficulty climbing stairs (HP:0003551) | 1.59504954 |
| 173 | Neuronal loss in central nervous system (HP:0002529) | 1.58253627 |
| 174 | Bronchiectasis (HP:0002110) | 1.56806861 |
| 175 | Aneurysm (HP:0002617) | 1.54602104 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NTRK3 | 4.02105509 |
| 2 | MAP3K9 | 3.40737905 |
| 3 | MARK1 | 2.65081170 |
| 4 | MAP3K4 | 2.62492158 |
| 5 | MINK1 | 2.60762787 |
| 6 | BCR | 2.48230151 |
| 7 | PRKD3 | 2.44787035 |
| 8 | NTRK1 | 2.41308672 |
| 9 | KSR2 | 2.32809818 |
| 10 | MAP3K12 | 2.17075535 |
| 11 | EPHA4 | 2.15435462 |
| 12 | EPHB1 | 2.14132521 |
| 13 | PAK6 | 2.12681616 |
| 14 | FGFR3 | 2.08471866 |
| 15 | MAP2K7 | 2.07600217 |
| 16 | DAPK2 | 2.04116936 |
| 17 | CAMKK1 | 1.99266997 |
| 18 | FGFR4 | 1.94517184 |
| 19 | NEK9 | 1.88739042 |
| 20 | MAP3K2 | 1.84097142 |
| 21 | CAMKK2 | 1.76411676 |
| 22 | MAP3K6 | 1.72760326 |
| 23 | UHMK1 | 1.66920449 |
| 24 | NTRK2 | 1.66640986 |
| 25 | MAP2K4 | 1.64747278 |
| 26 | JAK1 | 1.60268759 |
| 27 | LMTK2 | 1.57961503 |
| 28 | PRKCH | 1.48296419 |
| 29 | RET | 1.46815759 |
| 30 | CDK5 | 1.46074408 |
| 31 | TRIB3 | 1.45046302 |
| 32 | SCYL2 | 1.43614386 |
| 33 | KSR1 | 1.42204519 |
| 34 | YES1 | 1.37049586 |
| 35 | TRIM28 | 1.32568164 |
| 36 | PAK3 | 1.32500678 |
| 37 | DAPK1 | 1.30296429 |
| 38 | CASK | 1.30286846 |
| 39 | PHKG1 | 1.27912462 |
| 40 | PHKG2 | 1.27912462 |
| 41 | CDK19 | 1.19541606 |
| 42 | MAP3K1 | 1.17511979 |
| 43 | PLK2 | 1.17198875 |
| 44 | WNK3 | 1.13425541 |
| 45 | ARAF | 1.11176961 |
| 46 | NEK6 | 1.08604753 |
| 47 | GRK5 | 1.07846536 |
| 48 | DYRK1B | 1.07604315 |
| 49 | STK38 | 1.03141019 |
| 50 | PDGFRA | 1.01995669 |
| 51 | SGK223 | 1.01734690 |
| 52 | SGK494 | 1.01734690 |
| 53 | STK38L | 0.99256067 |
| 54 | PRPF4B | 0.99223453 |
| 55 | TTN | 0.96227862 |
| 56 | NEK1 | 0.95724947 |
| 57 | INSRR | 0.95243395 |
| 58 | PRKCG | 0.94907340 |
| 59 | CDK14 | 0.94564437 |
| 60 | HIPK2 | 0.93600387 |
| 61 | PDGFRB | 0.93550107 |
| 62 | PIK3CA | 0.93266746 |
| 63 | LATS1 | 0.92507243 |
| 64 | CDC42BPA | 0.91636491 |
| 65 | RIPK1 | 0.89266840 |
| 66 | LIMK1 | 0.88299537 |
| 67 | SGK3 | 0.88265525 |
| 68 | MAPK13 | 0.87954076 |
| 69 | TAOK1 | 0.87655360 |
| 70 | CDK18 | 0.85424978 |
| 71 | MAP3K5 | 0.84752710 |
| 72 | SGK2 | 0.84150544 |
| 73 | ALK | 0.83030122 |
| 74 | FGR | 0.82470955 |
| 75 | FER | 0.82225397 |
| 76 | CDK15 | 0.81630577 |
| 77 | MYLK | 0.81145869 |
| 78 | WNK1 | 0.80500317 |
| 79 | SIK3 | 0.80462451 |
| 80 | WNK4 | 0.80409116 |
| 81 | ROCK2 | 0.79815377 |
| 82 | JAK2 | 0.77908978 |
| 83 | PKN2 | 0.77713878 |
| 84 | CAMK2A | 0.76928214 |
| 85 | CSK | 0.76891417 |
| 86 | PTK2B | 0.76524434 |
| 87 | SIK2 | 0.75129088 |
| 88 | TYRO3 | 0.70554323 |
| 89 | FES | 0.70110663 |
| 90 | CDK11A | 0.69826737 |
| 91 | FGFR2 | 0.69804506 |
| 92 | CAMK1 | 0.69521211 |
| 93 | CDK6 | 0.69080055 |
| 94 | TRPM7 | 0.68976858 |
| 95 | MAPK15 | 0.66153219 |
| 96 | BMPR2 | 0.65020159 |
| 97 | LATS2 | 0.64583034 |
| 98 | MAP2K1 | 0.64507079 |
| 99 | MAP3K13 | 0.63150091 |
| 100 | RPS6KA2 | 0.62876162 |
| 101 | PTK2 | 0.61026725 |
| 102 | CAMK2D | 0.59843140 |
| 103 | PDK1 | 0.59766040 |
| 104 | MAP3K14 | 0.59755740 |
| 105 | PINK1 | 0.59677645 |
| 106 | STK11 | 0.59484990 |
| 107 | PRKCE | 0.59471670 |
| 108 | CSNK1G2 | 0.59141268 |
| 109 | TESK1 | 0.57387556 |
| 110 | DMPK | 0.56953918 |
| 111 | MARK2 | 0.56526531 |
| 112 | PDPK1 | 0.55794173 |
| 113 | CAMK2B | 0.55755035 |
| 114 | MET | 0.55591668 |
| 115 | CSNK1A1L | 0.54985057 |
| 116 | TGFBR2 | 0.54774407 |
| 117 | MAPK7 | 0.53395853 |
| 118 | MAPK12 | 0.51591274 |
| 119 | BRD4 | 0.51226674 |
| 120 | RIPK4 | 0.49778477 |
| 121 | RAF1 | 0.49418026 |
| 122 | CAMK2G | 0.49047368 |
| 123 | ICK | 0.48836616 |
| 124 | IRAK1 | 0.48288322 |
| 125 | SGK1 | 0.48130099 |
| 126 | ERBB2 | 0.46348763 |
| 127 | RPS6KB1 | 0.45891330 |
| 128 | MAPK10 | 0.45816619 |
| 129 | ERBB3 | 0.45168165 |
| 130 | BRSK1 | 0.44624032 |
| 131 | MOS | 0.44009123 |
| 132 | FYN | 0.43056795 |
| 133 | DYRK1A | 0.42158331 |
| 134 | ROCK1 | 0.41799077 |
| 135 | PDK3 | 0.41314438 |
| 136 | PDK4 | 0.41314438 |
| 137 | EPHA3 | 0.40830643 |
| 138 | PRKD1 | 0.40761906 |
| 139 | RPS6KA3 | 0.40503103 |
| 140 | AKT3 | 0.39359718 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.19588107 |
| 2 | Nicotine addiction_Homo sapiens_hsa05033 | 2.40791699 |
| 3 | Insulin secretion_Homo sapiens_hsa04911 | 2.37790249 |
| 4 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.36721884 |
| 5 | Circadian entrainment_Homo sapiens_hsa04713 | 2.32762487 |
| 6 | GABAergic synapse_Homo sapiens_hsa04727 | 2.27944182 |
| 7 | Olfactory transduction_Homo sapiens_hsa04740 | 2.26095422 |
| 8 | Long-term potentiation_Homo sapiens_hsa04720 | 2.19504126 |
| 9 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.14444325 |
| 10 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 2.07537862 |
| 11 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.04432068 |
| 12 | Morphine addiction_Homo sapiens_hsa05032 | 2.02746438 |
| 13 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.01808678 |
| 14 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.83124282 |
| 15 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.75063851 |
| 16 | Cocaine addiction_Homo sapiens_hsa05030 | 1.72737387 |
| 17 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.71234254 |
| 18 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.69659345 |
| 19 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.62238261 |
| 20 | Salivary secretion_Homo sapiens_hsa04970 | 1.61161730 |
| 21 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.58669183 |
| 22 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.55659286 |
| 23 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.54727740 |
| 24 | Taste transduction_Homo sapiens_hsa04742 | 1.53704047 |
| 25 | Renin secretion_Homo sapiens_hsa04924 | 1.51109768 |
| 26 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.46511841 |
| 27 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.42095794 |
| 28 | Long-term depression_Homo sapiens_hsa04730 | 1.36245794 |
| 29 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.35463166 |
| 30 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.35198507 |
| 31 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.26327901 |
| 32 | Gap junction_Homo sapiens_hsa04540 | 1.25781183 |
| 33 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.24846172 |
| 34 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.23929837 |
| 35 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.15081105 |
| 36 | Adherens junction_Homo sapiens_hsa04520 | 1.14292342 |
| 37 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.13849124 |
| 38 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.12968940 |
| 39 | Glioma_Homo sapiens_hsa05214 | 1.12186688 |
| 40 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.09449761 |
| 41 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.08115615 |
| 42 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.06051327 |
| 43 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.03716761 |
| 44 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.03468439 |
| 45 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.02027040 |
| 46 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.98524080 |
| 47 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.97494889 |
| 48 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.96592071 |
| 49 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.95694362 |
| 50 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.95371331 |
| 51 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.92609631 |
| 52 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.90520439 |
| 53 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.89726142 |
| 54 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.89335083 |
| 55 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.88730183 |
| 56 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.87586725 |
| 57 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.87469501 |
| 58 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.87020130 |
| 59 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.86740219 |
| 60 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.86724694 |
| 61 | Melanogenesis_Homo sapiens_hsa04916 | 0.86406062 |
| 62 | Amoebiasis_Homo sapiens_hsa05146 | 0.86043799 |
| 63 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.83678720 |
| 64 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.83628638 |
| 65 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.81660447 |
| 66 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.81555892 |
| 67 | Phagosome_Homo sapiens_hsa04145 | 0.81167441 |
| 68 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.77477364 |
| 69 | Axon guidance_Homo sapiens_hsa04360 | 0.77403477 |
| 70 | Circadian rhythm_Homo sapiens_hsa04710 | 0.77267400 |
| 71 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.72817460 |
| 72 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.72767185 |
| 73 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.72740233 |
| 74 | Endocytosis_Homo sapiens_hsa04144 | 0.72444100 |
| 75 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.72142444 |
| 76 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.71982095 |
| 77 | Tight junction_Homo sapiens_hsa04530 | 0.71849119 |
| 78 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.71641497 |
| 79 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.70820895 |
| 80 | Bile secretion_Homo sapiens_hsa04976 | 0.70706931 |
| 81 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.69927430 |
| 82 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.69841185 |
| 83 | Endometrial cancer_Homo sapiens_hsa05213 | 0.69315119 |
| 84 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.69168339 |
| 85 | * Insulin signaling pathway_Homo sapiens_hsa04910 | 0.68713919 |
| 86 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.67605580 |
| 87 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.67558253 |
| 88 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.67508384 |
| 89 | Histidine metabolism_Homo sapiens_hsa00340 | 0.66331713 |
| 90 | ABC transporters_Homo sapiens_hsa02010 | 0.65424764 |
| 91 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.65214701 |
| 92 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.63883471 |
| 93 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.63543983 |
| 94 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.63014889 |
| 95 | Prion diseases_Homo sapiens_hsa05020 | 0.61326003 |
| 96 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.60540030 |
| 97 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.60395603 |
| 98 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.56854001 |
| 99 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.56171495 |
| 100 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.56019592 |
| 101 | Salmonella infection_Homo sapiens_hsa05132 | 0.56012348 |
| 102 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.54253933 |
| 103 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.54114312 |
| 104 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.53357458 |
| 105 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.50803885 |
| 106 | Colorectal cancer_Homo sapiens_hsa05210 | 0.50572494 |
| 107 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.49979389 |
| 108 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.49504417 |
| 109 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.48756622 |
| 110 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.48031814 |
| 111 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.47909995 |
| 112 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.47904850 |
| 113 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.45089736 |
| 114 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.44772642 |
| 115 | Insulin resistance_Homo sapiens_hsa04931 | 0.40650972 |
| 116 | Lysosome_Homo sapiens_hsa04142 | 0.40437157 |
| 117 | Alcoholism_Homo sapiens_hsa05034 | 0.40129879 |
| 118 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.38289815 |
| 119 | Platelet activation_Homo sapiens_hsa04611 | 0.36861267 |
| 120 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.36812947 |
| 121 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.36038038 |
| 122 | Focal adhesion_Homo sapiens_hsa04510 | 0.34983469 |
| 123 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.34236212 |
| 124 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.33123466 |
| 125 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.33040615 |

